Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Globus Medical (NYSE:GMED), a medical device company that focuses on musculoskeletal spinal implants to promote healing, surged as much as 11% following the company's first-quarter results released after the closing bell last night.
So what: For the quarter, Globus Medical reported revenue of $114.2 million, up 8.8% from the year prior period, with sales in the U.S. rising 5.6%, and international sales soaring 43%, although making up only 10.9% of total sales. Adjusted net income also grew 14.6% to $22.8 million, or $0.24 per share, from $19.9 million, or $0.21, in the year-ago quarter. By comparison, Wall Street had been expecting just $0.22 in EPS on $113.7 million in sales. This marked Globus' sixth consecutive EPS beat.
Now what: As with most medical device companies, Globus Medical appears to make a lot of sense on paper. An aging population coupled with the rollout of Obamacare should translate into more doctor visits and potentially the need for more musculoskeletal implants down the road. Of course, it's not as cut-and-dried as that over the long run for Globus. The potential for ongoing Medicare reimbursement cuts as well as the medical device excise tax from Obamacare are both factors that could negatively weigh on Globus. Overall, I do believe its operations in a niche segment will deliver the long-term growth investors are looking for, but I would suggest investors temper their expectations moving forward, as Globus shares are already up around 65% over the past year.
Globus Medical may have soared today, but over the long haul, its gains may pale in comparison to this top stock
Give me five minutes, and I'll show how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks one stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year, his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.
Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.
Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.